UK markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
58.94+0.06 (+0.10%)
As of 3:39PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
No. of analysts1161111
Avg. Estimate0.11-0.24-0.24-0.56
Low estimate-0.34-0.45-0.74-1.52
High estimate2.4502.132.67
Year ago EPS0.11-0.030.69-0.24
Revenue estimateCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
No. of analysts1061011
Avg. Estimate21.33M19.45M101.62M127.75M
Low estimate8.8MN/A89.1M17.5M
High estimate48M45.9M128.4M483.5M
Year ago sales43.29M29.5M168.8M101.62M
Sales growth (year/est)-50.70%-34.10%-39.80%25.70%
Earnings history29/09/201930/12/201930/03/202029/06/2020
Est. EPS0.16-0.01-0.11-0.12
Actual EPS0.11-0.03-0.2-0.13
Difference-0.05-0.02-0.09-0.01
Surprise %-31.20%-200.00%-81.80%-8.30%
EPS trendCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
Current estimate0.11-0.24-0.24-0.56
7 days ago0.11-0.24-0.24-0.56
30 days ago-0.13-0.27-0.49-0.94
60 days ago-0.12-0.27-0.48-0.92
90 days ago-0.18-0.32-0.51-0.97
EPS revisionsCurrent qtr. (Sep 2020)Next qtr. (Dec 2020)Current year (2020)Next year (2021)
Up last 7 days1113
Up last 30 days1113
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesARWRIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.-700.00%N/AN/AN/A
Current year-134.80%N/AN/AN/A
Next year-133.30%N/AN/AN/A
Next 5 years (per annum)7.33%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A